http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107846-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0661268c68e416422070cc2ac577a4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_282bd64e1776b6b2423820fe870fc99d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00646
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H33-04
filingDate 2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2253767f8d985b542b7a1f74c7de21
publicationDate 2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005107846-A2
titleOfInvention Packaging for a therapeutic agent, consisting of a covering film, a non-woven film, and a therapeutic agent layer
abstract The invention relates to a packaging for a therapeutic agent for therapeutic applications, said packaging comprising a large-surface envelope (4) consisting of a covering film (2) and a non-woven film (3), and containing a therapeutic agent layer (5) of a pre-determined thickness, the covering film (2) and the non-woven film (3) being interconnected on the edges (6) thereof. Said covering film (2) consists of a liquid-tight and gas-tight tear-proof material and the non-woven film (3) consists of a porous material which is permeable to the active ingredients of the therapeutic agent (5). Said therapeutic agent comprises a carbohydrate-containing or protein-containing foodstuff in a moist and/or dry form, especially quark, and/or potato and/or coffee in a moist and/or dry form. The non-woven film (3) is covered by a peelable, air-tight protective film (7). The envelope (4) consists of a plurality of parts or a plurality of separate chambers (8). The external shape of the packaging for the therapeutic agent is adapted to the external form of the body part of the patient to be treated.
priorityDate 2004-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-863875-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406284

Total number of triples: 18.